Karin Luttropp

779 total citations
23 papers, 377 citations indexed

About

Karin Luttropp is a scholar working on Molecular Biology, Nephrology and Rheumatology. According to data from OpenAlex, Karin Luttropp has authored 23 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Nephrology and 6 papers in Rheumatology. Recurrent topics in Karin Luttropp's work include Epigenetics and DNA Methylation (5 papers), Rheumatoid Arthritis Research and Therapies (5 papers) and Autoimmune and Inflammatory Disorders Research (4 papers). Karin Luttropp is often cited by papers focused on Epigenetics and DNA Methylation (5 papers), Rheumatoid Arthritis Research and Therapies (5 papers) and Autoimmune and Inflammatory Disorders Research (4 papers). Karin Luttropp collaborates with scholars based in Sweden, United States and United Kingdom. Karin Luttropp's co-authors include Louise Nordfors, Peter Stenvinkel, Martin Schalling, Bengt Lindholm, Tomas J. Ekström, Juan Jesús Carrero, Abdul Rashid Qureshi, Samira Salihović, Tove Fall and Johanna Penell and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Karin Luttropp

23 papers receiving 373 citations

Peers

Karin Luttropp
Amira F. Gohara United States
R. W. Chesney United States
Laura J. Smyth United Kingdom
Janet Addison Switzerland
E.J. Nouwen Belgium
Elisavet Vasilopoulou United Kingdom
Karin Luttropp
Citations per year, relative to Karin Luttropp Karin Luttropp (= 1×) peers Vinay Singh Tanwar

Countries citing papers authored by Karin Luttropp

Since Specialization
Citations

This map shows the geographic impact of Karin Luttropp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Luttropp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Luttropp more than expected).

Fields of papers citing papers by Karin Luttropp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karin Luttropp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Luttropp. The network helps show where Karin Luttropp may publish in the future.

Co-authorship network of co-authors of Karin Luttropp

This figure shows the co-authorship network connecting the top 25 collaborators of Karin Luttropp. A scholar is included among the top collaborators of Karin Luttropp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin Luttropp. Karin Luttropp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Witasp, Anna, Karin Luttropp, Abdul Rashid Qureshi, et al.. (2022). Longitudinal genome-wide DNA methylation changes in response to kidney failure replacement therapy. Scientific Reports. 12(1). 470–470. 13 indexed citations
2.
Dalén, Johan, Amy Puenpatom, Karin Luttropp, Axel Svedbom, & Christopher M. Black. (2021). Treatment Persistence in Patients Cycling on Subcutaneous Tumor Necrosis Factor-Alpha Inhibitors in Inflammatory Arthritis: A Retrospective Study. Advances in Therapy. 39(1). 244–255. 4 indexed citations
3.
Luttropp, Karin, Johan Dalén, Axel Svedbom, et al.. (2020). <p>Real-World Patient Experience of Switching Biologic Treatment in Inflammatory Arthritis and Ulcerative Colitis – A Systematic Literature Review</p>. Patient Preference and Adherence. Volume 14. 309–320. 14 indexed citations
4.
Dalén, Johan, Karin Luttropp, Axel Svedbom, Christopher M. Black, & Sumesh Kachroo. (2020). Healthcare-Related Costs Associated with Switching Subcutaneous Tumor Necrosis Factor-α Inhibitor in the Treatment of Inflammatory Arthritis: a Retrospective Study. Advances in Therapy. 37(9). 3746–3760. 3 indexed citations
5.
Luttropp, Karin, Mary Dozier, Nahila Justo, et al.. (2019). Real-world treatment persistence of golimumab in the management of immune-mediated rheumatic diseases in Europe: a systematic literature review. BMJ Open. 9(5). e027456–e027456. 20 indexed citations
6.
Dalén, Johan, M Ivergård, Rebekah H. Borse, et al.. (2019). The value of persistence in treatment with subcutaneous TNF-alpha inhibitors for ankylosing spondylitis. The European Journal of Health Economics. 21(1). 45–54. 4 indexed citations
7.
Dalén, Johan, Axel Svedbom, Karin Luttropp, & Sumesh Kachroo. (2018). THU0666 Costs associated with switching subcutaneous tumour necrosis factor-Α inhibitor in the treatment of immune-mediated rheumatic disease. Annals of the Rheumatic Diseases. 77. 527–527. 2 indexed citations
8.
Luttropp, Karin, Małgorzata Dębowska, Leon Bobrowski, et al.. (2016). Genotypic and phenotypic predictors of inflammation in patients with chronic kidney disease. Nephrology Dialysis Transplantation. 31(12). 2033–2040. 7 indexed citations
9.
Luttropp, Karin, Louise Nordfors, Dagmara McGuinness, et al.. (2016). Increased Telomere Attrition After Renal Transplantation—Impact of Antimetabolite Therapy. Transplantation Direct. 2(12). e116–e116. 15 indexed citations
10.
Luttropp, Karin, Louise K. Sjöholm, & Tomas J. Ekström. (2015). Global Analysis of DNA 5-Methylcytosine Using the Luminometric Methylation Assay, LUMA. Methods in molecular biology. 1315. 209–219. 7 indexed citations
11.
Bobrowski, Leon, Bengt Lindholm, Peter Stenvinkel, et al.. (2014). Selection of Genetic and Phenotypic Features Associated with Inflammatory Status of Patients on Dialysis Using Relaxed Linear Separability Method. PLoS ONE. 9(1). e86630–e86630. 5 indexed citations
12.
Lind, Lars, Johanna Penell, Karin Luttropp, et al.. (2013). Global DNA hypermethylation is associated with high serum levels of persistent organic pollutants in an elderly population. Environment International. 59. 456–461. 82 indexed citations
13.
Nordfors, Louise, Karin Luttropp, Juan Jesús Carrero, et al.. (2012). Genetic studies in chronic kidney disease: basic concepts. Journal of Nephrology. 25(2). 141–149. 8 indexed citations
14.
Witasp, Anna, Louise Nordfors, Juan Jesús Carrero, et al.. (2012). Genetic studies in chronic kidney disease: interpretation and clinical applicability. Journal of Nephrology. 25(6). 851–864. 7 indexed citations
15.
Kato, Sawako, Bengt Lindholm, Peter Stenvinkel, et al.. (2012). DNA Hypermethylation and Inflammatory Markers in Incident Japanese Dialysis Patients. SHILAP Revista de lepidopterología. 2(1). 159–168. 16 indexed citations
16.
Karimi, Mohsen, Karin Luttropp, & Tomas J. Ekström. (2011). Global DNA Methylation Analysis Using the Luminometric Methylation Assay. Methods in molecular biology. 791. 135–144. 19 indexed citations
17.
Muntinghe, Friso L. H., Marion Verduijn, Mike W. Zuurman, et al.. (2009). CCR5 Deletion Protects Against Inflammation-Associated Mortality in Dialysis Patients. Journal of the American Society of Nephrology. 20(7). 1641–1649. 63 indexed citations
18.
Luttropp, Karin, Bengt Lindholm, Juan Jesús Carrero, et al.. (2009). Progress in Uremic Toxin Research: Genetics/Genomics in Chronic Kidney Disease—Towards Personalized Medicine?. Seminars in Dialysis. 22(4). 417–422. 19 indexed citations
19.
Chmielewski, Michael S., Peter Stenvinkel, Karin Luttropp, et al.. (2008). Lipoprotein Lipase 1595 C/G and Hepatic Lipase –480 C/T Polymorphisms – Impact on Lipid Profile in Incident Dialysis Patients. Blood Purification. 26(6). 555–560. 2 indexed citations
20.
Luttropp, Karin, Peter Stenvinkel, Juan Jesús Carrero, et al.. (2008). Understanding the role of genetic polymorphisms in chronic kidney disease. Pediatric Nephrology. 23(11). 1941–1949. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026